We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A National Registry of Patients With Hepatocellular Carcinoma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00178867
First Posted: September 15, 2005
Last Update Posted: October 10, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Vanderbilt University
September 12, 2005
September 15, 2005
October 10, 2008
January 2002
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00178867 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A National Registry of Patients With Hepatocellular Carcinoma
A National Registry of Patients With Hepatocellular Carcinoma
A registry of patients with the diagnosis of hepatocellular carcinoma.
The purpose of this research is to study the factors which might cause hepatocellular carcinoma (a form of cancer arising within the liver) and compare these factors in patients from different ethnic groups and from different parts of the United States. The researchers will also conduct a survey of the stage of the cancer (how far advanced it is) and what treatments are used for this difficult-to-treat tumor.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
All patients seen in Hepatobiliary Surgery Clinic at Vanderbilt University Medical Center who are diagnosed with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
August 2008
Not Provided

Inclusion Criteria:

  • Patients with diagnosis of hepatocellular carcinoma

Exclusion Criteria:

  • Patients can not be under 18 years of age
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00178867
020116
No
Not Provided
Not Provided
Ravi Chari, MD, Vanderbilt University
Vanderbilt University
Not Provided
Principal Investigator: Ravi S Chari, MD Vanderbilt University
Vanderbilt University
October 2008